Literature DB >> 25738069

Tretinoin Nanogel 0.025% Versus Conventional Gel 0.025% in Patients with Acne Vulgaris: A Randomized, Active Controlled, Multicentre, Parallel Group, Phase IV Clinical Trial.

B S Chandrashekhar1, M Anitha2, Mukesh Ruparelia3, Pradyumna Vaidya4, Riyaz Aamir5, Sunil Shah6, S Thilak7, Sanjeev Aurangabadkar8, Sandeep Pal9, Abir Saraswat10, Jayesh J Sanmukhani11.   

Abstract

BACKGROUND: Conventional topical tretinoin formulation is often associated with local adverse events. Nanogel formulation of tretinoin has good physical stability and enables good penetration of tretinoin into the pilo-sebaceous glands. AIM: The present study was conducted to assess the efficacy and safety of a nanogel formulation of tretinoin as compared to its conventional gel formulation in the treatment of acne vulgaris of the face.
MATERIALS AND METHODS: This randomized, active controlled, multicentric, phase IV clinical trial evaluated the treatment of patients with acne vulgaris of the face by the two gel formulations locally applied once daily at night for 12 wk. Acne lesion counts (inflammatory, non-inflammatory & total) and severity grading were carried out on the monthly scheduled visits along with the tolerability assessments.
RESULTS: A total of 207 patients were randomized in the study. Reductions in the total (72.9% vs. 65.0%; p = 0.03) and inflammatory (78.1% vs. 66.9%; p = 0.02) acne lesions were reported to be significantly greater with the nanogel formulation as compared to the conventional gel formulation. Local adverse events were significantly less (p = 0.04) in the nanogel group (13.3%) as compared to the conventional gel group (24.7%). Dryness was the most common adverse event reported in both the treatment groups while peeling of skin, burning sensation and photosensitivity were reported in patients using the conventional gel only.
CONCLUSION: In the treatment of acne vulgaris of the face, tretinoin nanogel formulation appears to be more effective and better tolerated than the conventional gel formulation.

Entities:  

Keywords:  Acne vulgaris; Nanogel; Tretinoin

Year:  2015        PMID: 25738069      PMCID: PMC4347160          DOI: 10.7860/JCDR/2015/10663.5469

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  25 in total

1.  Topical liposomal gel of tretinoin for the treatment of acne: research and clinical implications.

Authors:  V B Patel; A Misra; Y S Marfatia
Journal:  Pharm Dev Technol       Date:  2000       Impact factor: 3.133

2.  A novel surfactant nanoemulsion with a unique non-irritant topical antimicrobial activity against bacteria, enveloped viruses and fungi.

Authors:  T Hamouda; A Myc; B Donovan; A Y Shih; J D Reuter; J R Baker
Journal:  Microbiol Res       Date:  2001       Impact factor: 5.415

3.  Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery.

Authors:  Jie Liu; Wen Hu; Huabing Chen; Qian Ni; Huibi Xu; Xiangliang Yang
Journal:  Int J Pharm       Date:  2006-08-15       Impact factor: 5.875

4.  Clinical efficacy and safety comparison of adapalene gel and tretinoin gel in the treatment of acne vulgaris: Europe and U.S. multicenter trials.

Authors:  W J Cunliffe; R Caputo; B Dreno; L Förström; M Heenen; C E Orfanos; Y Privat; A Robledo Aguilar; J Meynadier; M Alirezai; S Jablonska; A Shalita; J S Weiss; D K Chalker; C N Ellis; A Greenspan; H I Katz; I Kantor; L E Millikan; J M Swinehart; L Swinyer; C Whitmore; J Czernielewski; M Verschoore
Journal:  J Am Acad Dermatol       Date:  1997-06       Impact factor: 11.527

Review 5.  New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne group.

Authors:  Diane Thiboutot; Harald Gollnick; Vincenzo Bettoli; Brigitte Dréno; Sewon Kang; James J Leyden; Alan R Shalita; Vicente Torres Lozada; Diane Berson; Andrew Finlay; Chee Leok Goh; María Isabel Herane; Ana Kaminsky; Raj Kubba; Alison Layton; Yoshiki Miyachi; Montserrat Perez; Jaime Piquero Martin; Marcia Ramos-E-Silva; Jo Ann See; Neil Shear; John Wolf
Journal:  J Am Acad Dermatol       Date:  2009-05       Impact factor: 11.527

6.  Double-blind, vehicle-controlled, multicenter comparison of two 0.025% tretinoin creams in patients with acne vulgaris.

Authors:  A W Lucky; S I Cullen; T Funicella; M T Jarratt; T Jones; M E Reddick
Journal:  J Am Acad Dermatol       Date:  1998-04       Impact factor: 11.527

7.  Cutting edge: all-trans retinoic acid down-regulates TLR2 expression and function.

Authors:  Philip T Liu; Stephan R Krutzik; Jenny Kim; Robert L Modlin
Journal:  J Immunol       Date:  2005-03-01       Impact factor: 5.422

Review 8.  Topical retinoids. Their uses in dermatology.

Authors:  M Verschoore; M Bouclier; J Czernielewski; C Hensby
Journal:  Dermatol Clin       Date:  1993-01       Impact factor: 3.478

9.  Investigation on the photostability of a tretinoin lotion and stabilization with additives.

Authors:  M Brisaert; J Plaizier-Vercammen
Journal:  Int J Pharm       Date:  2000-04-10       Impact factor: 5.875

10.  Tretinoin gel microspheres 0.04% versus 0.1% in adolescents and adults with mild to moderate acne vulgaris: a 12-week, multicenter, randomized, double-blind, parallel-group, phase IV trial.

Authors:  Richard Berger; Ronald Rizer; Alicia Barba; David Wilson; Daniel Stewart; Rachel Grossman; Marge Nighland; Jonathan Weiss
Journal:  Clin Ther       Date:  2007-06       Impact factor: 3.393

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.